Clinical Efficacy of Silodosin in Patients with Severe Lower Urinary Tract Symptoms Related to Benign Prostatic Obstruction: A Pooled Analysis of Phase 3 and 4 Trials

This publication has 9 references indexed in Scilit:

• Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans
  BMC Urology, 2018
• Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study
  BMC Urology, 2018
• Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: A European phase IV clinical study (SiRE study)
  International Journal of Urology, 2016
• Relationship between Lifestyle and Health Factors and Severe Lower Urinary Tract Symptoms (LUTS) in 106,435 Middle-Aged and Older Australian Men: Population-Based Study
  PLOS ONE, 2014
• Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe
  European Urology, 2011
• Do α₁‐adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?
  Neurourology and Urodynamics, 2008
• Evaluation of the Clinical Benefit of Permixon and Tamsulosin in Severe BPH Patients—PERMAL Study Subset Analysis
  European Urology, 2004
• One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire
  Urology, 2000
• Estimate Criteria for Efficacy of Treatment in Benign Prostatic Hyperplasia
  International Journal of Urology, 1996